Sage Journals: Discover world-class research

Retricted access

Research article

First published 2020-10

Weight Outcomes With Empagliflozin as Compared With Liraglutide in Veterans With Type 2 Diabetes Mellitus

Ted Robert Grabarczyk, Natalie Koury Wissman

Annals of Pharmacotherapy

Open access

Research article

First published 2016-3

IDegLira Improves Both Fasting and Postprandial Glucose Control as Demonstrated Using Continuous Glucose Monitoring and a Standardized Meal Test

Jens J. Holst, John B. Buse, Helena W. Rodbard [...]

Journal of Diabetes Science and Technology

Free access

Other

First published 2011-7

Cardiovascular safety of liraglutide assessed in a patient-level pooled analysis of phase 2—3 liraglutide clinical development studies

Steven P Marso, Jason B Lindsey, Joshua M Stolker [...]

Diabetes & Vascular Disease Research

Retricted access

Research article

First published 2025-10

Comparing the Efficacy of Liraglutide and Semaglutide on Weight Loss: Experience from the Middle East Gulf Region and Literature Review

Wasim S. El Nekidy, Haneen Hasan, Emna Abidi [...]

Hospital Pharmacy

Open access

Brief report

First published 2018-9

Cardiovascular outcomes in patients who experienced a myocardial infarction while treated with liraglutide versus placebo in the LEADER trial

Michael A Nauck, Karen Tornøe, Søren Rasmussen [...]

Diabetes & Vascular Disease Research

Retricted access

Research article

First published 2026-1

Adherence and Effectiveness of Liraglutide in Adolescents with Obesity

Shlomit Yaron, Ronen Arbel, Talish Razi [...]

Childhood Obesity

Retricted access

Research article

First published 2018-7

Assessment of Cardiovascular Risk With Glucagon-Like Peptide 1 Receptor Agonists in Patients With Type 2 Diabetes Using an Alternative Measure to the Hazard Ratio

Masayuki Kaneko, Mamoru Narukawa

Annals of Pharmacotherapy

Open access

Brief report

First published 2024

Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database

Afsaneh Shirani, Anne H. Cross, Olaf Stuve

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2020

Antidiabetic Drugs for the Risk of Alzheimer Disease in Patients With Type 2 DM Using FAERS

Hayato Akimoto, Akio Negishi, Shinji Oshima [...]

American Journal of Alzheimer's Disease & Other Dementias®

Open access

Research article

First published 2026

Comparative efficacy and safety of liraglutide versus metformin,naltrexone/bupropion,and phentermine-topiramate in psychiatric patients

Won-Seok Choi, Min-Kyu Song, Mansuk Seo [...]

Therapeutic Advances in Psychopharmacology

Search results